ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 186 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $8,304,000 | -9.4% | 667,499 | -0.3% | 0.01% | -9.1% |
| Q3 2016 | $9,168,000 | +86.6% | 669,672 | +0.7% | 0.01% | +83.3% |
| Q2 2016 | $4,913,000 | +30.7% | 664,847 | +13.0% | 0.01% | +20.0% |
| Q1 2016 | $3,759,000 | +6.7% | 588,332 | +4.4% | 0.01% | 0.0% |
| Q4 2015 | $3,522,000 | +7.3% | 563,474 | +0.3% | 0.01% | +25.0% |
| Q3 2015 | $3,281,000 | -30.1% | 561,742 | -1.1% | 0.00% | -33.3% |
| Q2 2015 | $4,697,000 | +25.0% | 567,997 | +24.5% | 0.01% | +20.0% |
| Q1 2015 | $3,759,000 | +21.9% | 456,151 | +1.6% | 0.01% | +25.0% |
| Q4 2014 | $3,084,000 | +25.9% | 448,920 | -1.0% | 0.00% | +33.3% |
| Q3 2014 | $2,449,000 | -14.8% | 453,585 | +0.5% | 0.00% | -25.0% |
| Q2 2014 | $2,875,000 | +473.9% | 451,299 | +626.4% | 0.00% | +300.0% |
| Q1 2014 | $501,000 | +16.5% | 62,127 | -1.4% | 0.00% | 0.0% |
| Q4 2013 | $430,000 | -86.2% | 63,037 | -62.7% | 0.00% | -80.0% |
| Q3 2013 | $3,106,000 | +132.3% | 168,791 | +120.8% | 0.01% | +150.0% |
| Q2 2013 | $1,337,000 | – | 76,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,331,100 | $23,281,000 | 8.28% |
| DAFNA Capital Management LLC | 191,215 | $3,344,000 | 4.89% |
| Redmile Group, LLC | 1,277,109 | $22,337,000 | 3.94% |
| BB BIOTECH AG | 3,115,371 | $54,488,000 | 3.92% |
| SECTORAL ASSET MANAGEMENT INC | 5,292,682 | $92,569,000 | 2.74% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 565,956 | $9,899,000 | 1.76% |
| OAK RIDGE INVESTMENTS LLC | 2,645,781 | $46,275,000 | 1.45% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,265,104 | $22,127,000 | 1.04% |
| Tekla Capital Management LLC | 412,965 | $7,223,000 | 0.98% |
| Private Capital Advisors, Inc. | 127,600 | $2,232,000 | 0.83% |